Episode 180: Health equity 'tourism,' an $11B biopharma acquisition, & a bony Covid protest The Readout Loud
-
- Business
First, we welcome STAT reporter Usha Lee McFarling onto the podcast to discuss her investigation into health equity tourism — how white scholars are colonizing research on health disparities. Then, we "chatty Cathy" a blizzard of biotech news from this week, including Merck's $11 billion acquisition of Acceleron Pharma, a theatrical street protest about the Covid vaccine equity dive, a debate about gene therapy's future, and, finally, why Scott Gottlieb is looking up at Elvira.
First, we welcome STAT reporter Usha Lee McFarling onto the podcast to discuss her investigation into health equity tourism — how white scholars are colonizing research on health disparities. Then, we "chatty Cathy" a blizzard of biotech news from this week, including Merck's $11 billion acquisition of Acceleron Pharma, a theatrical street protest about the Covid vaccine equity dive, a debate about gene therapy's future, and, finally, why Scott Gottlieb is looking up at Elvira.
28 min